Health Condition 1: N948- Other specified conditions associated with female genital organs and menstrual cycle
Conditions
Interventions
None listed
Sponsors
Dr Palla Suneela
Eligibility
Inclusion criteria
Inclusion criteria: Patients with diagnostic criterion of any two of three features: anovulation or oligo-ovulation, clinical and/or biochemical hyperandrogenism, and polycystic ovarian morphology (PCOM) seen on ultrasound will be taken for study
Exclusion criteria
Exclusion criteria: Patients having primary PCOS, congenital anomalies, Malignancies, Hyperandrogenemia due to other causes like adrenal hyperplasia, Cushing’s syndrome etc., cardiac diseases, neurological diseases and severe respiratory diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Subjective parameters like interval and duration of menstruation, hirsutism, acne and Objective parameters like Change in USG findings in Ovarian volume and no of folliclesTimepoint: Assessment will be done before intervention( baseline), immediatly after study( 45 days of drug administration) and 6 weeks after stopping the drug. | — |
Secondary
| Measure | Time frame |
|---|---|
| quantity of bleeding, dysmenorrhoea, S. Androgen levels, S.AMH levels, S. HbA1C levels, other USG findingsTimepoint: Assessment will be done before intervention( baseline), immediatly after study( 45 days of drug administration) & 6 weeks after stopping the drug. | — |
Countries
India
Contacts
Public ContactDr P Suneela
Mandsaur Institute of Ayurveda Education & Research, Mandsaur University, Mandsaur
Outcome results
None listed